Single-use Bioprocessing Market
Single-use Bioprocessing Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Simple & Peripheral Elements, Apparatus & Plants, Work Equipment
- By Workflow Upstream Bioprocessing, Fermentation, Downstream Bioprocessing
- By End-use Biopharmaceutical Manufacturers, Academic & Clinical Research Institutes
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 11.5 Billion |
Revenue 2032: | USD 57.35 Billion |
Revenue CAGR (2024 - 2032): | 19.6% |
Fastest Growing Region (2024 - 2032) | Asia Pacific |
Largest Region (2023): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Sr. No. | Offering | Report Coverage |
1. | Market Size | In terms of Revenue (USD Million) |
2. | Historic Data | 2018 to 2022 |
3. | Forecast Data | 2024 to 2032 |
4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
5. | Market Attractiveness Analysis | Yes |
6. | Segment Analysis | Maximum Segments |
7. | Regional Coverage | 5 Regions |
8. | Country Coverage | Top 22 Countries |
9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
10. | Porter’s Five Forces Analysis | Yes. |
11. | Value Chain Analysis | Yes |
12. | PEST Analysis | Yes |
13. | Regulatory Landscape | Yes |
14. | Technology Landscape | Yes |
15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
16. | Top startups to watch out for | Yes |
17. | Top 3 Trends to Watch | Yes |
18. | Top 3 Strategies Followed by Major Players | Yes |
19. | Top 3 Predictions by Vantage Market Research | Yes |
20. | Discussion Guide | Yes |
21. | Key Primary Respondents - VERBATIM | Yes |
22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
23. | Others/Miscellaneous |
FAQ
Frequently Asked Question
What is the global demand for Single-use Bioprocessing in terms of revenue?
-
The global Single-use Bioprocessing valued at USD 11.5 Billion in 2023 and is expected to reach USD 57.35 Billion in 2032 growing at a CAGR of 19.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Avantor Inc. (U.S.), Eppendorf SE (Germany), Sartorius AG (Germany), Lonza Group AG (Switzerland), PBS Biotech Inc. (U.S.), Meissner Filtration Products Inc. (U.S.), Danaher Corp. (U.S.), Corning Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 19.6% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Single-use Bioprocessing include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Single-use Bioprocessing in 2023.